Gu Yubei

Professor, Jiaotong University Ruijin Hospital,Shanghai,China /Advanced IBD fellowship in Cleveland Clinic #IBD #Enteroscope #AOCCMember

[Gu Yubei @YubeiGu]

7th APAGE-#IBD

[Intestinal Research @Intest_Res]

Long-term clinical and endoscopic efficacy of vedolizumab and therapeutic persistence in patients with ulcerative colitis in China: a multicenter observational study
https://t.co/ybg9QzDZod

[Gu Yubei @YubeiGu]

@TakuKobayashiM1 @BDYE_IBD @sang_hyoung @Sung_Wook_Hwang @EdwardLoftus2 @ShintaroAkiyam2 @DrSagami @FernandoMagro6 @silvio_silvio75 @vipuljairath @DONGHYUNKI55634 Why we have a gap in picture3, my chair?

[Gu Yubei @YubeiGu]

#AOCC2026 👏👏👏

[Gu Yubei @YubeiGu]

@sang_hyoung @AsanIbd @EdwardLoftus2 @EunjaGwon @DONGHYUNKI55634 👏👏👏

[Intestinal Research @Intest_Res]

🎉 Intestinal Research has achieved a 2025 Impact Factor of 4.7 and advanced to Q1 in the Gastroenterology & Hepatology category!

A heartfelt thank you to our authors, reviewers, editorial board members, and readers for your continued support.

[theKASID @theKASID]

"Honored to have Prof. Minhu Chen share his congratulatory message for AOCC 2026 & IMKASID 2026!🙌Don't miss his full message below. Get ready for an incredible scientific journey with us!"📷
https://t.co/4O65VuYkoM
#AOCC #IMKASID

[Edmund Wu, MD @edmundwumd]

Honored to moderate the first AOCC-CCC session and serve on the Education Committee of Asian Organization of Crohn’s & Colitis. Great discussion with IBD experts from across Asia 🇨🇳🇭🇰🇮🇳🇯🇵🇰🇷🇲🇾🇸🇬🇹🇼

[Gu Yubei @YubeiGu]

@NiyaziN6 Sorry, only the co-authors can get the copy. Others should buy it😊

[Gu Yubei @YubeiGu]

Congrats the New book 📕 has coming
The best gift to New 2026
Thanks Dr Bo Shen lead us collect and record our daily endoscopy images day by day.
Congrats to ‘Atlas of Endoscopy Imaging in Inflammatory bowel disease’ again.
#IBD

[Gu Yubei @YubeiGu]

@DrXiaoGIPath Many thanks 😊

[Gu Yubei @YubeiGu]

3 years of hard work🥹, made the chance to give a presentation at #ECCO
Proud of my Univ, and proud of our study group👏👏👏

[Gu Yubei @YubeiGu]

Looking forward to see everyone in Stockholm
#ECCO2026 #IBD

[Gu Yubei @YubeiGu]

@DrXiaoGIPath 额……

[Gu Yubei @YubeiGu]

@EndoCollabcom If it is the single lesion, Malt lymphoma can not exclude. If it is multiple lesion, CMUSE or CEAS need to consider

[Gu Yubei @YubeiGu]

@dralexleow 😁I appreciate his EUS technique so much. But he is not familiar with IUS😁😁😁😁

[Shintaro Akiyama / 秋山 慎太郎 @ShintaroAkiyam2]

Our multinational Asian PSC-IBD study has been published! Across 25 hospitals in 6 Asian countries, we evaluated >50,000 IBD patients:
PSC prevalence: 0.92% overall
UC: 1.4%
CD: 0.13%
👉 Lower than Western cohorts.
Thanks all 🙌 @sang_hyoung @AGA_CGH
https://t.co/p7nFg3ps5R

[Gu Yubei @YubeiGu]

🙈Walking on a tightrope
🌸The first tough UC case successfully treated by Guselkumab in China #IBD

[Gu Yubei @YubeiGu]

Cooperation with Jichi Medical university. innovation is the soul of endoscopy forever.
#Smallbowel